Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Sucampo Pharmaceuticals, Inc.    SCMP   US8649091068

 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
12.66(c) 12.89(c) 13.42(c) 13.44(c) 13.57(c) Last
405 415 299 664 295 538 305 829 470 888 Volume
-9.12% +1.82% +4.11% +0.15% +0.97% Change
More quotes
Company
Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company which engages in research, discovery, development and commercialization of proprietary drugs based on prostones and other novel drug technologies.Prostones are naturally occurring fatty acid metabolites with unique physiological... 
More about the company
Surperformance© ratings of Sucampo Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Chart SUCAMPO PHARMACEUTICALS, I
Duration : Period :
Sucampo Pharmaceuticals, I Technical Analysis Chart | SCMP | US8649091068 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 120 M
EBIT 2014 34,1 M
Net income 2014 10,9 M
Finance 2014 16,5 M
Yield 2014 -
Sales 2015 131 M
EBIT 2015 40,0 M
Net income 2015 23,9 M
Finance 2015 54,6 M
Yield 2015 -
PER 2014 63,86
PER 2015 25,36
EV / Sales 2014 4,89x
EV / Sales 2015 4,19x
Capitalization 602 M
More Financials
Latest news on SUCAMPO PHARMACEUTICALS, I
5d ago Sucampo Appoints John H. Johnson to Board of Directors
11/25 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the 26th Annu..
11/12 SUCAMPO PHARMACEUTICALS : Files Patent Infringement Lawsuit Against Dr. Reddy's
11/12 SUCAMPO PHARMACEUTICALS : Regulation FD Disclosure (form 8-K)
11/11 SUCAMPO PHARMACEUTICALS : Announces Webcast of Its Presentation at the Stifel 20..
11/07 SUCAMPO PHARMACEUTICALS : Management's Discussion and Analysis of Financial Cond..
11/06 SUCAMPO PHARMACEUTICALS : posts 3Q profit
11/06 SUCAMPO PHARMACEUTICALS : Results of Operations and Financial Condition, Regulat..
More news
Sector news
1d ago ISIS PHARMACEUTICALS : IWM, HEZU: Big ETF Inflows
1d ago PUMA BIOTECHNOLOGY : SHAREHOLDER ALERT: Investigation on Behalf of Investors of ..
1d ago ALNYLAM PHARMACEUTICALS : Announces Planned Departure of Chief Business Officer,..
More sector news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF